I am delighted to announce we have now concluded our consultation on funding for community pharmacy for 2024-25 and 2025-26. We have agreed with Community Pharmacy England that in 2025-26 the funding will increase to £3.073 billion, an increase of £375 million compared to 2024-25. This means, in addition to other changes, that on a like- for-like basis the value of the funding will increase by 15.0% compared to 2024-25, compared to 5.8% growth to the budget of the NHS as a whole. This is on top of a consolidated increase in 2024-25 of 4.1%.
This investment will enable us to embed and build on the range of clinical services that we commission from community pharmacy as we seek to improve access through reform and better use the skills of pharmacy teams to keep people well in their communities.
In addition, we have agreed to allow pharmacies to keep £193 million of funding that was paid to them primarily over the pandemic period to support the vital supply of medicines. This will bring more certainty of funding for contractors and support pharmacies in purchasing the medication prescribed for patients.
We know that community pharmacy has been neglected. We are determined to work with the sector to get it back on its feet and delivering for patients. This agreement with CPE will provide much needed investment and start to stabilise the community pharmacy sector. It marks a show of confidence in this Government to deliver the left shift—moving care from hospital to community, and moving from sickness to prevention.
I would like to pay tribute to CPE’s committee. I am grateful to them for working constructively and at pace with officials to agree how best to use this significant new investment to support the sector, and to continue to provide services to patients across the country. We have prioritised patient access to medication, support and advice. We are also embedding and extending the clinical service offer. We will provide additional support for people newly prescribed medication for depression, as well as offering access to NHS provided emergency hormonal contraception across the country for the first time.
We have also committed £215 million to grow the Pharmacy First service, as we look to build on the over 1.9 million consultations already delivered as of November 2024 and provide a platform for prescribing services in the future.
These services will continue to increase the access and support available for people close to home, in the heart of their communities.
I am therefore very pleased to share this announcement and look forward to continued collaborative working with Community Pharmacy England and the wider sector as we build on what we have announced today and deliver what we all want for community pharmacy, a service fit for the future.
[HCWS570]